SB 262

INSPECT program.

Law

Jurisdiction

Indiana

Session

2026 Session

Last updated at

Jun 17, 2026, 3:23 PM

Official source

Take action

Introduced
Passed Senate
Passed House
To Governor
Became Law

Bill overview

Sets forth the circumstances in which a dispenser is not required to transmit certain information to the INSPECT program (program). Requires an opioid treatment program to, before reporting patient information to the program, comply with federal regulations in obtaining patient consent. Allows the board of pharmacy to disclose prescription drug monitoring program data to a representative of the Indiana department of health and the office of the secretary of family and social services for specified purposes.

Positions across the state

No public positions recorded for this legislation.

Arguments in favor

Reasons to support this legislation.

No arguments in favor have been submitted.

Submit yours

Arguments opposed

Reasons to oppose this legislation.

No arguments opposed have been submitted.

Submit yours

Chronological record of actions on this bill from official records.

2026-03-05Senate

Signed by the Governor

Vote map

House districts

Loading map data

0 districts with vote data

Nay

Yea

Floor votes and chamber actions

Recorded roll calls list how each member voted. Unanimous consent or voice vote appears in the official action history without a roll call; no member-level tally is available for those steps.

Recorded roll calls

Read the latest version inline or switch to a previous version.

SB 262

Take action

Bill overview

Sponsors

Primary sponsors

Cosponsors

Sponsor

Positions across the state

Arguments in favor

Arguments opposed

Legislative history

Vote map

Floor votes and chamber actions

Recorded roll calls

Bill text

Positions across the state

Legislative history

Vote map

Floor votes and chamber actions

Recorded roll calls